{"id":60406,"date":"2021-06-02T13:37:25","date_gmt":"2021-06-02T08:07:25","guid":{"rendered":"https:\/\/newsmakhani.com\/?p=60406"},"modified":"2021-06-02T13:37:25","modified_gmt":"2021-06-02T08:07:25","slug":"centre-takes-steps-to-accelerate-domestic-vaccine-production","status":"publish","type":"post","link":"https:\/\/newsnarad.com\/pa\/centre-takes-steps-to-accelerate-domestic-vaccine-production\/","title":{"rendered":"Centre takes steps to accelerate domestic vaccine production"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-pa\">\u0a2e\u0a3e\u0a2b\u0a3c \u0a15\u0a30\u0a28\u0a3e, \u0a07\u0a39 \u0a16\u0a2c\u0a30 \u0a24\u0a41\u0a39\u0a3e\u0a21\u0a40 \u0a2c\u0a47\u0a28\u0a24\u0a40 \u0a2d\u0a3e\u0a38\u0a3c\u0a3e \u0a35\u0a3f\u0a71\u0a1a \u0a09\u0a2a\u0a32\u0a2c\u0a27 \u0a28\u0a39\u0a40\u0a02 \u0a39\u0a48\u0964 <a href=\"https:\/\/newsmakhani.com\/en\/\">\u0a15\u0a3f\u0a30\u0a2a\u0a3e \u0a15\u0a30\u0a15\u0a47 \u0a07\u0a71\u0a25\u0a47 \u0a26\u0a47\u0a16\u0a4b\u0964<\/a><\/p><p><\/p>\n<h5 class=\"MinistryNameSubhead text-center\"><span style=\"color: #222222\">Haffkine Biopharma to produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech<\/span><\/h5>\n<h5 class=\"ReleaseDateSubHeaddateTime text-center pt20\">Mumbai 02 JUN 2021<\/h5>\n<p>With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with help from the Centre.<\/p>\n<p>As part of this initiative, three public enterprises are being supported by\u00a0 the Department of Biotechnology under Atmanirbhar Bharat 3.0\u00a0 Mission Covid Suraksha.\u00a0 These enterprises are the<\/p>\n<p>1. Haffkine Biopharmaceutical Corporation Ltd, Mumbai,<\/p>\n<p>2. Indian Immunologicals Ltd, Hyderabad and<\/p>\n<p>3. Bharat Immunologicals &amp; Biologicals Ltd, Bulandshahar, UP.<\/p>\n<p>Haffkine Biopharma, a Maharashtra state PSU is getting ready to manufacture Covaxin vaccine under technology transfer arrangement with Bharat Biotech Ltd, Hyderabad.\u00a0 The production will take place at the Parel complex of the company.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/static.pib.gov.in\/WriteReadData\/userfiles\/image\/IMG_20210602_104730C00H.jpg\" alt=\"\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>Dr. Sandeep Rathod, Managing Director of Haffkine BioPharma said the company proposes to produce 22.8 crore doses of Covaxin in a year.\u00a0 \u201cFor undertaking production of Covaxin, Haffkine Biopharma has been provided with Rs 65 crore grant by the Centre and Rs 94 crore from the Government of Maharashtra\u201d he added.<\/p>\n<p>&nbsp;<\/p>\n<p>\u201cWe have been given a timeline of eight months and the work is being executed on a war footing. The vaccine production process involves two stages \u2013 drug substance and final drug product.\u00a0 For production of drug substance we need to build a Bio Safety Level 3 (BSL 3) facility, while Haffkine already has the Fill Finish facility\u201d said Rathod, the doctor turned IAS officer.\u00a0 BSL 3 is a safety standard applicable to such facilities where work involves microbes which can cause serious disease via inhalation route.<\/p>\n<p>\u2018Enhancing vaccine production capacity using Public sectors assets will go a long way in building production capacity of vaccines in our country to support the massive vaccination drive\u201d said, Dr Renu Swarup,\u00a0 Secretary Department of Biotechnology and Chairperson BIRAC (Biotechnology Industry Research Assistance Council )<\/p>\n<p>Haffkine BioPharmaceutical Corporation Ltd is an offshoot of the 122 year old Haffkine Institute, which is one of the oldest biomedical research institutes in the country, named after the Russian\u00a0 bacteriologist Dr. Waldemar Haffkine, who invented the plague vaccine.<\/p>\n<p>&nbsp;<\/p>\n<p>Sources :<\/p>\n<p>\u2022 Department of Biotechnology background note.<\/p>\n<p>\u2022 Interview with Dr. Sandeep Rathod, MD, Haffkine Biopharma, Mumbai<\/p>\n<p>Message for TV News Channels \/ YouTube channels.<\/p>\n<p>Haffkine Biopharma video feed available through ANI<\/p>","protected":false},"excerpt":{"rendered":"<p>\u0a2e\u0a3e\u0a2b\u0a3c \u0a15\u0a30\u0a28\u0a3e, \u0a07\u0a39 \u0a16\u0a2c\u0a30 \u0a24\u0a41\u0a39\u0a3e\u0a21\u0a40 \u0a2c\u0a47\u0a28\u0a24\u0a40 \u0a2d\u0a3e\u0a38\u0a3c\u0a3e \u0a35\u0a3f\u0a71\u0a1a \u0a09\u0a2a\u0a32\u0a2c\u0a27 \u0a28\u0a39\u0a40\u0a02 \u0a39\u0a48\u0964 \u0a15\u0a3f\u0a30\u0a2a\u0a3e \u0a15\u0a30\u0a15\u0a47 \u0a07\u0a71\u0a25\u0a47 \u0a26\u0a47\u0a16\u0a4b\u0964 Haffkine Biopharma to produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech Mumbai 02 JUN 2021 With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":60413,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1528,1563,109,122],"tags":[31652,31649,31650,31653,4657,20584,962,18397,16517,283,31646,31648,31654,11582,31651,31647,15516,12740,31512,31645],"class_list":{"0":"post-60406","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-covid-19","8":"category-health","9":"category-national","10":"category-news","11":"tag-bharat-immunologicals-biologicals-ltd","12":"tag-birac","13":"tag-bsl","14":"tag-bulandshahar","15":"tag-covid-care-center","16":"tag-covid-crisis","17":"tag-covid-pandemic","18":"tag-covid-update","19":"tag-covid-vaccination","20":"tag-covid-19","21":"tag-dr-sandeep-rathod","22":"tag-haffkine-biopharma","23":"tag-haffkine-biopharmaceutical-corporation-ltd","24":"tag-hyderabad","25":"tag-indian-immunologicals-ltd","26":"tag-md","27":"tag-ministry-of-science-technology","28":"tag-mumbai","29":"tag-ramped","30":"tag-sources"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/posts\/60406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/comments?post=60406"}],"version-history":[{"count":0,"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/posts\/60406\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/media\/60413"}],"wp:attachment":[{"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/media?parent=60406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/categories?post=60406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsnarad.com\/pa\/wp-json\/wp\/v2\/tags?post=60406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}